Overview of Deblok
| Property | Description |
|---|---|
| Active Ingredient | Ibuprofen (INN) |
| Form | Oral Solid Dosage (e.g., tablet, capsule) |
| Pharmacological Class | Nonsteroidal Anti-Inflammatory Drug (NSAID) |
| General Purpose | Relief from pain, inflammation, and fever |
| Origin | Synthetic Propionic Acid Derivative |
Deblok is a proprietary medicine whose core component is the widely known compound Ibuprofen (INN), a foundational Nonsteroidal Anti-Inflammatory Drug (NSAID) used to manage pain, inflammation, and fever. This pharmaceutical entity is classified as a synthetic propionic acid derivative and achieves its versatile therapeutic effects by interrupting specific biochemical signals within the body.
Deblok: Classification and Core Active Ingredient
Deblok is categorized as an NSAID, a class of medication recognized for its dual capacity to relieve pain and reduce swelling. Its single active ingredient is Ibuprofen, a synthetic compound derived from propionic acid. Ibuprofen is utilized primarily for its analgesic, antipyretic, and anti-inflammatory properties. This NSAID classification is clinically recognized for providing effective symptomatic relief in common scenarios, such as general body aches or mild inflammatory states, distinguishing it from simpler analgesics that only target pain.
What Type of Medicine is Deblok? (Pharmacological Class and Form)
The drug entity Deblok is typically presented as an oral solid dosage form, such as a tablet or capsule, intended for oral administration. The compound, a propionic acid derivative, is a product of chemical synthesis, distinguishing its origin from naturally occurring substances. Ibuprofen exerts its therapeutic effect by inhibiting the enzyme cyclooxygenase (COX), thereby regulating the production of pain and inflammation mediators. The oral form ensures the active ingredient is absorbed into the bloodstream, allowing it to provide generalized relief across the body.
General Purpose and Physiological Effect
The general purpose of Deblok is to provide symptomatic relief across its three primary physiological actions: analgesic (pain-relieving), antipyretic (fever-reducing), and anti-inflammatory. It achieves these effects by acting as an inhibitor of the cyclooxygenase (COX) enzymes. By interrupting the synthesis of prostaglandins—chemical messengers that trigger inflammation and sensitize nerve endings—the medicine effectively diminishes the intensity of pain and swelling signals, establishing it as a foundational option for mitigating the systemic and localized effects of inflammatory responses.
Regulatory References
